Boehringer Ingelheim starts clinical development of fibrotic diseases treatment Ruchika Sharma10 May 2023 4:30 PM ISTIL-11 plays a key role in fibrosis across multiple organs and pre-clinical studies have shown that anti-IL-11 treatment has the potential to stop -...
Boehringer Ingelheim Spesolimab bags USFDA Breakthrough Therapy Designation for prevention of generalized pustular psoriasis flares Ruchika Sharma3 May 2023 2:30 PM ISTGeneralized pustular psoriasis is a rare and potentially life-threatening chronic neutrophilic skin disease characterized by flares of widespread...
Boehringer Ingelheim, Cognizant ink pact on Unified Cloud Platform to speed delivery of life saving therapies Ruchika Sharma13 April 2023 11:15 AM ISTBy bringing together Boehringer Ingelheim's clinical, regulatory, and quality functions onto this unified platform simultaneously, this holistic...
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
Boehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing Directors Ruchika Sharma22 Dec 2022 12:45 PM ISTThe appointment to the Board of Managing Directors will be effective July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.
Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment Spesolimab Ruchika Sharma14 Dec 2022 2:15 PM ISTPeople living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis.
Boehringer Ingelheim gets USFDA nod for SPEVIGO to treat generalized pustular psoriasis flares Ruchika Sharma3 Sept 2022 11:00 AM ISTRidgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has approved SPEVIGO, the first approved treatment...
Boehringer Ingelheim, Evotec and bioMérieux launch joint venture Aurobac Ruchika Sharma10 July 2022 2:00 PM ISTFrance: Boehringer Ingelheim, a research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux have announced that they...
Boehringer Ingelheim, A*STAR ink pact for targeted cancer therapies Ruchika Sharma4 Jun 2022 10:00 AM ISTA*STAR may receive payments totalling 100 million EUR in upfront and success-based development and commercialization milestones.
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
Violation of drugs patents: Boehringer Ingelheim demands mechanisms in place Roshni Dhar26 April 2022 2:20 PM ISTDrug major Boehringer Ingelheim India has urged authorities to put in place a system that will inform patent holders whenever an application is filed...
Health Bulletin 23/April/2022 Roshni Dhar23 April 2022 5:34 PM ISTHere are the Top Health stories of the day:Foreign MBBS medicos must secure 50 percent marks in 10+2 to appear in FMGE: Delhi HCDismissing the plea by...
